FY20 bloodbank reagent standing order with four option years
Ended Awarded Last action
- Contract number
- N0023219F9300
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $65,820
Award facts
- Contract value 100% obligated
- $65,820.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Newtown, PA 18940, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $13,180 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $13,180 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $13,180 | |
| Funding Only Action | -$80 | |
| Exercise an Option | $0 | |
| Funding Only Action | $13,180 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $520 | |
| Original award | $12,660 |
Show all 12
About this award
This is a firm-fixed-price delivery order awarded by the Defense Health Agency (DHA) to Alba Bioscience, Inc., a for-profit organization that specializes in in vitro diagnostics and blood bank reagents. The award, valued at $65,820.25, is for FY20 BLOODBANK REAGENT STANDING ORDER with four option years, and is placed against the GSA Schedule 65-VII for in vitro diagnostics, reagents, and tests. The contract is not designated with a set-aside.
Alba Bioscience, a subsidiary of Quotient Biodiagnostics, Inc., is a leading supplier of specialized biomedical products supporting blood banking operations across government healthcare systems. This delivery order will provide critical medical supplies such as antibody screening cells, antibodies, additives, and quality control kits to support diagnostic testing, blood typing, and transfusion services for federal healthcare facilities.
In addition to this delivery order, Alba Bioscience holds two significant Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs - a single-award Blanket Purchase Agreement (BPA) with Veterans Integrated Service Network 10 valued at $109,420.35, and a multiple-award BPA with Veterans Integrated Service Network 1 valued at $30,000. These IDVs enable VA medical facilities to efficiently procure critical blood banking supplies through streamlined ordering processes.
Quick answers
Who was awarded contract N0023219F9300?
N0023219F9300 was awarded to Alba Bioscience, Inc. by Defense Health Agency (Department of Defense) on October 1, 2019.
How much is contract N0023219F9300 worth?
The government has obligated $65,820 on N0023219F9300.
Is contract N0023219F9300 an order under another contract?
Yes. N0023219F9300 is a delivery order under V797P2050D, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract N0023219F9300 competed?
The extent of competition for N0023219F9300 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award